Haemopoietic stem cell inhibition: Potential for dose intensification
- 30 September 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (10) , 1586-1591
- https://doi.org/10.1016/0959-8049(95)00302-y
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factorsEuropean Journal Of Cancer, 1994
- Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy [see comments]Blood, 1992
- Stem cell proliferation inhibitorsBailliere's Clinical Haematology, 1992
- Identification and characterization of an inhibitor of haemopoietic stem cell proliferationNature, 1990
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- HAEMOPOIETIC GROWTH FACTORS 2: CLINICAL APPLICATIONSThe Lancet, 1989
- HAEMOPOIETIC GROWTH FACTORS 1The Lancet, 1989
- Phase I trials of WR-2721 and cis-platinumInternational Journal of Radiation Oncology*Biology*Physics, 1984
- A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.Journal of Clinical Oncology, 1983
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980